论文部分内容阅读
目的:观察灯盏细辛注射液治疗糖尿病合并脑梗死的疗效。方法:60例糖尿病合并脑梗死患者随机分为治疗组和对照组。治疗组30例应用灯盏细辛注射液40mL加入生理盐水250mL中静脉滴注。对照组30例应用川芎嗪注射液160mg加入生理盐水250mL中静脉滴注。两组患者均每日1次,14d为1个疗程。结果:治疗组总有效率(90%)明显高于对照组(77%)(P<0.05)。治疗组用药前后血液流变学指标中血液黏度指标均有明显改善。结论:灯盏细辛注射液治疗糖尿病合并脑梗死疗效确切,安全可靠。
Objective: To observe the curative effect of Dengzhanxixin injection on diabetic patients with cerebral infarction. Methods: Sixty diabetic patients with cerebral infarction were randomly divided into treatment group and control group. Treatment group, 30 cases of Erigeron Injection 40mL normal saline 250mL intravenous infusion. Control group, 30 cases of ligustrazine injection 160mg normal saline 250mL intravenous infusion. Two groups of patients were daily 1, 14d for a course of treatment. Results: The total effective rate (90%) in the treatment group was significantly higher than that in the control group (77%) (P <0.05). Before and after treatment in the treatment group, the indexes of blood rheology in blood rheology indicators were significantly improved. Conclusion: Erigeron breviscapus injection for the treatment of cerebral infarction with diabetes is effective, safe and reliable.